Home Search
chemotherapy - search results
If you're not happy with the results, please do another search
Individualised Multimodal Immunotherapy beyond personalised medicine for brain cancer
Stefaan Van Gool, MD, PhD brings to light the important role of Individualised Multimodal Immunotherapy in improving the survival of brain cancer.
Scientists identify longest COVID infection, at 505 days
After a study of immunocompromised patients, UK researchers found the longest COVID infection case to be 505 days.
NHS patients face “postcode lottery” for fertility freezing treatments
Access to fertility freezing treatments is becoming more scarce, as UK policy guidelines on fertility preservation are rigorous and NHS funding is “variable”.
First case of woman cured from HIV, after dual stem-cell transplant
The first ever woman cured from HIV underwent a dual stem-cell transplant, which seems to have made her genetically resistant to HIV and put her cancer into remission.
Racial minorities 41% less likely to receive CPR during cardiac arrest
Racial minorities - Black and Hispanic people - are less likely to receive CPR when they need it, as bystanders give CPR significantly more often to white victims of cardiac arrest.
Cytomegalovirus & glioblastoma: Solving the riddle
Sean Lawler, Associate Professor at Brown University, explains solving the riddle when it comes to the cytomegalovirus virus and the lethal brain tumour, glioblastoma.
Giovanni Brandi – University of Bologna
Prof. Giovanni Brandi is Associate Professor in Medical Oncology at the University of Bologna (UNIBO, Italy) and head of the "Hepato-biliary and pancreatic tumors" Program at IRCSS, Azienda Ospedaliera Universitaria of Bologna (Italy).
Simona Tavolari – University of Bologna
Dr Simona Tavolari is adjunct Professor for the School of Specialization in Medical Oncology at University of Bologna (UNIBO, Italy) and research associate at Department of Experimental, Diagnostic and Specialty Medicine (UNIBO).
Therapeutic feline and canine cancer vaccine
Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.
A new wave of molecular cancer therapeutics
Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.
TheraVision: An oncolytic virus platform technology for a personalised virus-immunotherapy
Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.
Medical cannabis & the future of cancer treatments
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
Amyloidosis: A rare but devastating blood condition
Dr Peter Diamond, Head of Research from the Leukaemia Foundation, describes what we need to know about amyloidosis, a rare but devastating blood condition
Third known case of HIV remission after stem cell transplant
After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months
New potential therapy for aggressive bladder cancer
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
Drug for ovarian cancer shows 52% reduction in death
Scientists have began using trametinib – used to treat skin and lung cancers – for ovarian cancer, showing that it can significantly slow the progression of the cancer.
Prospects for minimally invasive and optimally effective cancer immunotherapy
Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.
Drug gives 34% protection against lung cancer recurrence
The NHS have gained a new drug, atezolizumab, which can give 34% protection against lung cancer recurrence or death, post-chemotherapy.
Getting personal in brain tumour therapy: Matching therapies to patients
Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field
Artificial Intelligence solutions for healthcare delivery
Chaith Kondragunta, CEO at AIRA Matrix Private Limited, details Artificial Intelligence-based solutions that can positively impact prostate cancer outcomes.
